おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ANGECON
company
About
ANGECON focuses on the R&D of cell drugs, healthy cell storage and other fields.
- 11 - 50
Details
- Last Funding Type
- Angel
- Last Funding Money Raised
- ¥10M
- Industries
- Biotechnology,Health Care,Sales
- Founded date
- Feb 2, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥11.18M
ANGECON has raised a total of
¥11.18M
in funding over 2 rounds. Their latest funding was raised on
Sep 3, 2012 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 3, 2012 | Series A | ¥1.18M | 1 |
|
— | Detail |
| May 10, 2012 | Angel | ¥10M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
ANGECON is funded by 2 investors.
Fudewu Sheng
and Sanjie Touzi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
Yes | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
